BMP2 and congenital bilateral aplasia of vas deferens from CFTR mutation: Our findings show that miR-664a-3p participates in regulating AVIC osteogenic differentiation by negatively regulating BMP2 expression, highlighting that miR-664a-3p may be a potential therapeutic target for CAVD.